**Beauty Pie LED Mask Advertisement Banned for Misleading Claims**
An advertisement for Beauty Pie's LED face mask has been banned by the Advertising Standards Authority (ASA) due to misleading claims regarding its effectiveness in reducing wrinkles. The ad, which appeared on the London Underground in December, asserted that the mask was "clinically proven to reduce wrinkles in four weeks." However, the ASA determined that Beauty Pie did not provide sufficient evidence to support this assertion.
Beauty Pie, a direct-to-consumer cosmetics company known for its membership-based model, claimed that the mask had been tested on a group of 28 individuals aged between 30 and 65 over a four-week period. Despite these claims, the ASA criticized the small sample size as "relatively small," which raises concerns about the reliability of the results.
LED technology, while widely utilized in medical treatments for conditions such as eczema, acne, and psoriasis, has seen a surge in popularity for at-home use. The global market for LED devices is projected to reach £600 million by 2032, according to analysis from Skyquest. However, dermatologists have cautioned that there have not been sufficient clinical trials with large sample sizes or extended durations to definitively establish the benefits of at-home LED masks.
Beauty Pie's C-Wave Light Facial LED mask is priced at £199 for members and £299 for non-members, which the company claims is significantly lower than comparable products from competitors. The advertisement described the mask as "skin tech that's light years ahead," prompting the ASA to expect robust evidence specific to the product to substantiate such claims.
In response to the ASA's findings, Beauty Pie argued that their trial demonstrated a "significant reduction in wrinkles." They noted that 92% of participants either agreed or strongly agreed that their "fine lines appear less visible" after using the mask. However, the ASA pointed out that the testing methodology had significant limitations, including the absence of a placebo group and the relatively small number of participants.
Furthermore, the ASA highlighted that testers were instructed to use an exfoliating product and a hydrogel, neither of which are included with the mask. The organization stated that this additional context meant that the improvements in wrinkle appearance could not be solely attributed to the LED mask itself.
Beauty Pie contended that sample sizes of 20 to 25 participants are routinely accepted by other regulatory bodies. However, the ASA maintained that the additional studies cited by Beauty Pie were insufficient to substantiate the claim that the mask was clinically proven to reduce wrinkles within the specified timeframe.
The ASA concluded that the advertisement was misleading and directed Beauty Pie not to make similar claims unless they can provide adequate evidence to support them. The ruling underscores the importance of substantiating advertising claims, especially in the competitive and rapidly evolving beauty industry.
Beauty Pie has been contacted for further comment regarding the ruling and its implications for future advertising practices.